Teva Pharmaceutical Industries Ltd. ADR-0.46% $24.97B ...

Jefferies analyst Peter Welford maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The company’s shares closed last Friday at p1,359. ...

GSK (GSK) announced the European Commission has approved Jemperli, or dostarlimab, in combination with chemotherapy for first-line treatment of adult patients with primary advanced or recurrent ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.

GSK has shifted towards a global marketing model ... Richardson noted that the streaming service has around nine different promotional photos for each programme – and an algorithm picks the ...

After hours: January 17 at 7:25:46 p.m. EST ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

The biggest stories of the day delivered to your inbox.